Myostatin, Activin Or Activin Receptor Antagonists For Use In Treating Obesity And Related Conditions - EP3558361
EP3558361
- Filing Date
- Dec 20, 2017
- Status
- Granted
- Grant Date
- Aug 20, 2025
- External Links
- Slate, Register, Google Patents
Bibliography
The patent EP3558361B1 was granted to Novartis on Aug 20, 2025 following the initial filing on Dec 20, 2017 under the application number The current legal status of the patent is Granted.
Patent Summary
Patent Family New
Dossier Documents
The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.
Get instant alerts for new documents